Invention Publication
- Patent Title: [1,2,4]TRIAZOLO[1,5-A]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS
-
Application No.: US18307119Application Date: 2023-04-26
-
Publication No.: US20230255941A1Publication Date: 2023-08-17
- Inventor: Alaric J. DYCKMAN , Dharmpal S. Dodd , Tasir Shamsul Haque , Louis J. Lombardo , John E. Macor , Christopher P. Mussari , Laxman Pasunoori , Sreekantha Ratna Kumar , Trevor C. Sherwood , Shoshana L. Posy , Ramesh Kumar Sistla , Subramanya Hegde , Anupama Kandhi Ramachandra Reddy
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- Priority: IN 1611022328 2016.06.29
- Main IPC: A61K31/4196
- IPC: A61K31/4196 ; C07D249/00 ; A61K31/437 ; A61K31/4427 ; A61K45/06 ; C07D471/04
![[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS](/abs-image/US/2023/08/17/US20230255941A1/abs.jpg.150x150.jpg)
Abstract:
Disclosed are compounds of Formula (I)
or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
Information query